26B-1-402.  Rare Disease Advisory Council Grant Program — Creation — Reporting.

(1)  As used in this section:

Terms Used In Utah Code 26B-1-402

  • State: when applied to the different parts of the United States, includes a state, district, or territory of the United States. See Utah Code 68-3-12.5
  • United States: includes each state, district, and territory of the United States of America. See Utah Code 68-3-12.5
(a)  “Council” means the Rare Disease Advisory Council described in Subsection (3).

(b)  “Grantee” means the recipient of a grant under this section to operate the program.

(c)  “Rare disease” means a disease that affects fewer than 200,000 individuals in the United States.

(2) 

(a)  Within legislative appropriations, the department shall issue a request for proposals for a grant to administer the provisions of this section.

(b)  The department may issue a grant under this section if the grantee agrees to:

(i)  convene the council in accordance with Subsection (3);

(ii)  provide staff and other administrative support to the council; and

(iii)  in coordination with the department, report to the Legislature in accordance with Subsection (4).

(3)  The Rare Disease Advisory Council convened by the grantee shall:

(a)  advise the Legislature and state agencies on providing services and care to individuals with a rare disease;

(b)  make recommendations to the Legislature and state agencies on improving access to treatment and services provided to individuals with a rare disease;

(c)  identify best practices to improve the care and treatment of individuals in the state with a rare disease;

(d)  meet at least two times in each calendar year; and

(e)  be composed of members identified by the department, including at least the following individuals:

(i)  a representative from the department;

(ii)  researchers and physicians who specialize in rare diseases, including at least one representative from the University of Utah;

(iii)  two individuals who have a rare disease or are the parent or caregiver of an individual with a rare disease; and

(iv)  two representatives from one or more rare disease patient organizations that operate in the state.

(4)  Before November 30, 2021, and before November 30 of every odd-numbered year thereafter, the department shall report to the Health and Human Services Interim Committee on:

(a)  the activities of the grantee and the council; and

(b)  recommendations and best practices regarding the ongoing needs of individuals in the state with a rare disease.

Renumbered and Amended by Chapter 305, 2023 General Session